Controlling drug efficiency by encapsulation into carbon nanotubes: A theoretical study of the antitumor Cisplatin and the anti-HIV TIBO molecules.

التفاصيل البيبلوغرافية
العنوان: Controlling drug efficiency by encapsulation into carbon nanotubes: A theoretical study of the antitumor Cisplatin and the anti-HIV TIBO molecules.
المؤلفون: Bessrour, R., Belmiloud, Y., Hosni, Z., Tangour, B.
المصدر: AIP Conference Proceedings; 6/22/2012, Vol. 1456 Issue 1, p229-239, 11p
مصطلحات موضوعية: CISPLATIN, ANTI-HIV agents, DRUG efficacy, CONTROLLED release drugs, MICROENCAPSULATION, CARBON nanotubes, PHYSICAL & theoretical chemistry, ANTINEOPLASTIC agents
مستخلص: From the beginning of last century, Paul Ehrlich, a specialist in the immune system and the Nobel Prize (1908) had raised the possibility of "magic bullets" can directly address, in an organism, drugs in a particular area of the body, sparing all other parts of side effects. Carbon nanotubes (CNTs) have particular property to cross cell membranes easily. In an effort to optimize the use of CNT as drug nanocarriers, we divided our study into two parts. In the first, our concern was to find the minimum diameter of a single wall CNT can encapsulate an anticancer drug that iscisplatin without altering its geometry in order conserve its therapeutic power. Behavior of one and two Cisplatin(Cp) molecules confined in capped and opened single-walled carbon nanotubes (CNTs) is studied by means of ab-initio calculations. Single molecule binding energies clearly exhibit encapsulation dependence on tube diameters that range from 6.26 Å to 12.04 Å. A weak stabilization energy of the Cp@(11,0) equal to -70 kcal.mol-1 has been obtained corresponding to a CNT's diameter of 8.5Å. We noticed that Cisplatin molecule changes shape when encapsulated into CNTs' whose diameters are less than 7.6 Å. In the presence of a second Cisplatin molecule in the (10,0) CNT, preferred position stays parallel to CNT's axis leading to a linear density of roughly 1588 molecules/μm of CNT's length corresponding to a linear density of 7.9 10-19 g/μm. The 195Pt chemical shift tensors are calculated using GIAO method. NMR calculations reveal that Platinum chemical shift is sensitive to CNT's diameter and is linearly correlated to confinement energy. 195Pt chemical shift measurement may be a direct method to access to the diameter of the encapsulating CNT's and to control the amount of drug molecule transported by this CNT. In the second part, the opposite has been sought is to say how the use of nanotubes with different diameters can control the change in a geometry of an anti-HIV drug that is TIBO molecule to bypass the mutation of the virus which wiped out its therapeutic effect. This work deals with the butterfly conformation control of the anti-HIV TIBO molecule confined into carbon nanotubes (CNT). This theoretical study concerns the variation of some pertinent conformation descriptors such as butterfly angle, wingspan, volume, dipole moment, solvation energy and confinement energy versus carbon nanotube diameters. Obtained results show that it is possible to describe the configurations of actual drugs as 8-Cl or 9-Cl TIBO as the parent molecule TIBO encapsulated in an adequate CNT. Our approach indicates that drug confinement inside CNTs may be a promising way to use a same drug in order to fellow HIV virus mutations. [ABSTRACT FROM AUTHOR]
Copyright of AIP Conference Proceedings is the property of American Institute of Physics and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:0094243X
DOI:10.1063/1.4730664